statements

Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade OrderAvicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order

Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order

March 31, 2025 20:10 ET  | Source: Avicanna Inc. Auditor Licensing & Personnel Issues Delays Issuance of Audit OpinionThe Company…

1 month ago
Digihost Announces Restatement of Previously Issued Financial StatementsDigihost Announces Restatement of Previously Issued Financial Statements

Digihost Announces Restatement of Previously Issued Financial Statements

March 05, 2025 17:05 ET  | Source: Digihost Technology Inc. MIAMI, March 05, 2025 (GLOBE NEWSWIRE) -- Digihost Technology Inc.…

2 months ago
Ferrero Group reports Consolidated Financial Statements for the 2023/2024 Financial YearFerrero Group reports Consolidated Financial Statements for the 2023/2024 Financial Year

Ferrero Group reports Consolidated Financial Statements for the 2023/2024 Financial Year

The Ferrero Group continues its growth trajectory with an 8.9% increase in turnover to EUR18.4 billion.Continued innovation across new products…

3 months ago
PharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private PlacementPharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private Placement

PharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private Placement

TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a…

5 months ago
PharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private PlacementPharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private Placement

PharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private Placement

TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a…

5 months ago
Voxtur Announces Amendments to Financial Statements and MD&A forQ3 Ended September 30, 2024Voxtur Announces Amendments to Financial Statements and MD&A forQ3 Ended September 30, 2024

Voxtur Announces Amendments to Financial Statements and MD&A forQ3 Ended September 30, 2024

December 06, 2024 18:16 ET | Source: Voxtur Analytics Corp. TORONTO and TAMPA, Fla., Dec. 06, 2024 (GLOBE NEWSWIRE) --…

5 months ago
Voxtur Announces Amendments to Financial Statements and MD&A forQ3 Ended September 30, 2024Voxtur Announces Amendments to Financial Statements and MD&A forQ3 Ended September 30, 2024

Voxtur Announces Amendments to Financial Statements and MD&A forQ3 Ended September 30, 2024

December 06, 2024 18:16 ET | Source: Voxtur Analytics Corp. TORONTO and TAMPA, Fla., Dec. 06, 2024 (GLOBE NEWSWIRE) --…

5 months ago
Press Release: Availability of the revised financial statements for Sanofi excluding OpellaPress Release: Availability of the revised financial statements for Sanofi excluding Opella

Press Release: Availability of the revised financial statements for Sanofi excluding Opella

Availability of the revised financial statements for Sanofi excluding Opella Paris, France – December 6, 2024. Following the press release…

5 months ago